A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

The CHOIR trial in anemic patients with chronic kidney disease compared epoetin-alfa treatment with low (11.3 g/l) and high (13.5 g/l) hemoglobin targets on the composite end point of death, hospitalization for heart failure, stroke, and myocardial infarction. However, other anemia management trials...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Szczech, Lynda A., Barnhart, Huiman X., Sapp, Shelly, Felker, G. Michael, Hernandez, Adrian, Reddan, Donal, Califf, Robert M., Inrig, Jula K., Patel, Uptal D., Singh, Ajay K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2009
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902281/
https://ncbi.nlm.nih.gov/pubmed/19890274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2009.415
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia